title: Transforming growth factor-beta1 gene polymorphisms and coronary artery disease.
abstract: 1. Transforming growth factor-beta1 is a cytokine with a very wide spectrum of biological activities. Previous studies have shown that it is involved in a number of physiological and pathological processes including heart disease. In our study we aimed to scan the transforming growth factor-beta1 locus for polymorphisms and to identify haplotypes significantly associated with a predisposition to coronary atherosclerosis.2. Two patient groups comprising 244 angiographically normal individuals and 655 patients with coronary artery disease were recruited from London and Sheffield. DNA samples from these subjects were screened for mutations in the transforming growth factor-beta1 locus and all subjects were genotyped by a coupled polymerase chain reaction-restriction enzyme digestion method.3. Five polymorphisms have been identified in the transforming growth factor-beta1 gene at positions G-800A, C-509T in the promoter region, Leu10-->Pro, Arg25-->Pro in exon 1 and Thr263-->Ile in exon 5. No significant difference in frequencies for any of the five polymorphisms was found between controls and patients with coronary artery disease. Similarly, there was no correlation between these polymorphisms and hypertension.4. The genotypes of all the individuals participating in the study were assigned to seven main haplotypes of the transforming growth factor-beta1 locus. Based on species comparison data we propose that GCCGC is the ancestral haplotype in humans.5. Our data suggest that these transforming growth factor-beta1 polymorphisms are not associated with coronary artery disease and therefore their presence alone would not be a genetic risk factor for predisposition to coronary artery disease.
authors.affiliation: Medical Genetics Unit, St George's Hospital Medical School, Cranmer Terrace, London SW170RE, U.K.
authors.forename: P
authors.initials: P
authors.lastname: Syrris
authors.forename: N D
authors.initials: ND
authors.lastname: Carter
authors.forename: J C
authors.initials: JC
authors.lastname: Metcalfe
authors.forename: P R
authors.initials: PR
authors.lastname: Kemp
authors.forename: D J
authors.initials: DJ
authors.lastname: Grainger
authors.forename: J C
authors.initials: JC
authors.lastname: Kaski
authors.forename: D C
authors.initials: DC
authors.lastname: Crossman
authors.forename: S E
authors.initials: SE
authors.lastname: Francis
authors.forename: J
authors.initials: J
authors.lastname: Gunn
authors.forename: S
authors.initials: S
authors.lastname: Jeffery
authors.forename: K
authors.initials: K
authors.lastname: Heathcote
mesh_terms: D016022:Case-Control Studies; D016009:Chi-Square Distribution; D003327:Coronary Disease / Q000235:genetics*; D005260:Female; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D012307:Risk Factors; D016212:Transforming Growth Factor beta / Q000235:genetics*
chemical_list: D005819:Genetic Markers; D016212:Transforming Growth Factor beta